ロード中...
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
EGFR mutations represent the most common currently targetable oncogenic driver in non-small cell lung cancer. There has been tremendous progress in targeting this alteration over the course of the last decade, and third generation tyrosine kinase inhibitors offer previously unseen survival rates amo...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8044828/ https://ncbi.nlm.nih.gov/pubmed/33869038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.644472 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|